Recursion Pharmaceuticals, Inc. Company Profile & Data: stocks, market cap, financials, digital and more

                        
Company
Recursion Pharmaceuticals, Inc.Headquarters: Salt Lake City, 
                        UT, United States
                    
Employees: 330
CEO: Dr. Christopher C. Gibson Ph.D.

                                    NASDAQ: RXRX
                                
                                            -7.83%
                                            
Market Cap$3.12 Billion

                        USD as of Jan. 1, 2025
                    
                            Market Cap History

Recursion Pharmaceuticals, Inc. Categories

United States Healthcare Biotechnology
United States Healthcare United States Biotechnology

Recursion Pharmaceuticals, Inc. market capitalization over time

Evolution of Recursion Pharmaceuticals, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Recursion Pharmaceuticals, Inc.

Top Competitors by Market Capitalization

Industry: Biotechnology

Company	Market Cap (USD)
Novo Nordisk	$622.07 B
Vertex Pharmaceuticals Incorporated	$113.24 B
CSL Limited	$95.75 B
Regeneron Pharmaceuticals, Inc.	$76.33 B
Marinomed Biotech AG	$56.13 B

Sector:

Company	Market Cap (USD)
Lilly	$689.42 B
Novo Nordisk	$622.07 B
UnitedHealth Group	$487.54 B
Johnson & Johnson	$353.05 B
AbbVie	$301.60 B

Detailed Description

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Financials

Last Financial Reports Date	Sept. 30, 2024
Revenue TTM	$65.2 M
EBITDA	$-364,150,016
Gross Profit TTM	$1.3 M
Profit Margin	2.94%
Operating Margin	-377.10%
Quarterly Revenue Growth	147.60%